This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

What Does Braille Have to Do With Glaucoma?

“My advice for the blind community is to be prepared for what life may throw at you and be open to learn new things.” — Jasmyn Polite

Living with Glaucoma: Tonian McDonald’s Personal Story

Tonian strives to be a face for change and spread awareness of glaucoma in her country of Jamaica, and around the world.

New Medical Therapies Offer Hope for Glaucoma Patients

“It’s always exciting to have new and effective treatment alternatives available to help patients,” said Andrew Iwach, MD.

African Americans and Glaucoma

After cataracts, glaucoma is the leading cause of blindness in African Americans. Half of those with glaucoma don’t know they have it.

2018 Glaucoma Research Update: Dr. Andrew Huberman’s Laboratory

Andrew Huberman, PhD is a principal investigator in the Catalyst for a Cure Biomarkers Team funded by Glaucoma Research Foundation in San Francisco, CA.

2018 Glaucoma Research Update: Vivek Srinivasan’s Laboratory

The Srinivasan Laboratory at the University of California, Davis, develops novel optical imaging techniques and diagnostics with applications spanning from basic to clinical research.

2018 Glaucoma Research Update: Dr. Jeffrey Goldberg’s Laboratory at Stanford

Dr. Goldberg’s glaucoma research is directed at neuroprotection and regeneration of retinal ganglion cells and other retinal neurons.

New Dual Action Glaucoma Medication Promising for Glaucoma Patients

In November 2017, the FDA approved Vyzulta, latanoprostene bunod (LBN), as a potential game-changer in the treatment of glaucoma.

Why Retinal Ganglion Cells Are Important in Glaucoma

Retinal ganglion cells (RGCs) are particularly important in glaucoma because they are the cells that are damaged by the disease.

Help for Glaucoma Patients Who Lose Vision

You and your eye doctor share the same goal in the treatment of glaucoma: to preserve as much of your vision as possible, even if the disease progresses over time.

Spotlight on Research: Dr. Alfredo Dubra’s Laboratory at Stanford

“We’re not just trying to achieve some answer in terms of scientific curiosity, but our aim is to really help people who are suffering from this disease.” — Alfredo Dubra, PhD

Home IOP Measurements and Continuous IOP Monitors

If you are a glaucoma patient, it is important for you and your doctor to monitor your intraocular pressure (IOP).

A Remarkable Legacy: Robert and Virginia Shaffer

Robert Shaffer and his wife Virginia leave behind a remarkable legacy through their generous philanthropic support and lifelong dedication to teaching the next generation of glaucoma specialists.

Scientists Discover New Potential Glaucoma Treatment

Vision scientists have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma.

Researcher Spotlight: Andrew Huberman, PhD

Researchers like Dr. Andrew Huberman and the other Catalyst for a Cure scientists are focused on stopping blindness from glaucoma.

The Wittenbergs Honor their Glaucoma Doctor with Inspired Gift to The Cure is in Sight Campaign

The Glaucoma Research Foundation (GRF) mission to cure glaucoma is fueled by donations from many sources—much of it from patients, families, and friends touched by the disease.

Selective Laser Trabeculoplasty as Primary Glaucoma Therapy

Due to its excellent benefit-to-risk profile, selective laser trabeculoplasty, or SLT, is being offered earlier in the treatment strategy of glaucoma, including as primary therapy.

Dr. John Flanagan Joins Glaucoma Research Foundation Board and Continues Shaffer Grant Research

Dr. John Flanagan is actively working on research to discover new ways to treat glaucoma.

High Eye Pressure and Glaucoma

Q: I’ve heard that glaucoma is caused by high eye pressure, and that left untreated glaucoma can cause blindness. At what pressure will I go blind?

Dr. Elizabeth Fini Receives NIH Funding for Glaucoma Research, Thanks to GRF Shaffer Grant

Glaucoma Research Foundation (GRF) is dedicated to supporting promising research conducted by dedicated scientists.

A Practical Guide To The Best Medical Research Charities

If you’re looking for a medical research charity to support, you probably want to know with confidence that your donation is going to make an impact and help people.

4 Effective Ways to Encourage Medication Compliance in Glaucoma Patients

If patients feel supported in their day-to-day life, adhering to treatment and stopping glaucoma progression will more likely result.

New Nanoparticle Drug Delivery Can Help Enhance Glaucoma Treatments

Evidence is building that nanoparticles will prove an excellent drug delivery system, and it won’t be long until this technology reaches patients.

How Sleep Apnea May Contribute to Normal-Tension Glaucoma Risk

By using a new contact lens technology, researchers are hoping to gain new insight into obstructive sleep apnea by continuously monitoring the eye pressure even during sleep cycles.

Jasmyn Polite: My Battle with Glaucoma

“I want to teach visually impaired preschoolers everything they will need to prepare them for elementary school. I hope that I can be an inspiration to them.” — Jasmyn Polite